91大神

Katherine E. McGoogan, MD

Physician

91大神 Children's Health, Jacksonville 807 Children's Way Jacksonville, FL 32207

Biography

Katherine McGoogan is a pediatric gastroenterologist with a focus in pediatric hepatology. Her career focus has mainly been as a clinician. She participates in clinical research in pediatric gastroenterology including clinical trials in infant formula, medications for constipation/IBS-C, inflammatory bowel disease, and Zellweger's syndrome. Her clinical interests are in Hepatitis C, biliary atresia, and Alagille syndrome.

Fellowship

  • Pediatric Gastroenterology - University of Florida College of Medicine, 2011

Residency

  • Pediatrics - Duke University Medical Center, 2008

Education

  • B.A. University of Miami
  • M.D. - University of Miami, 2005

Board Certifications

  • American Board of Pediatrics/Gastroenterology

  • Energy- and protein-enriched formula improves weight gain in infants with malnutrition due to cardiac and noncardiac etiologies.; JPEN. Journal of parenteral and enteral nutrition; (2022).

  • A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.; American journal of human genetics; (2021).

  • Neonatal gastric lactobezoar: management with N-acetylcysteine.; Case reports in pediatrics; (2012).

  • Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.; Gene therapy; (2011).

  • High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors. ; Journal of visualized experiments : JoVE; (2011).

  • Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity.; The Journal of pediatrics; (2011).

  • Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis.; Journal of pediatric gastroenterology and nutrition; (2010).

  • Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3.; Human gene therapy; (2010).